Bayer, McNeil St. Joseph Aspirin Ad Dispute Moves To Federal Court
This article was originally published in The Tan Sheet
Executive Summary
A recent British Medical Journal study does not support McNeil Consumer & Specialty Pharmaceuticals' advertising claims that 81 mg aspirin "is just as effective as 325 mg in reducing the risk of recurrent heart attacks," Bayer says in a lawsuit filed in New York federal court April 25
You may also be interested in...
Aleve “Doctor Recommended” Ad Claim Has No “Reasonable Basis” – NAD
Bayer Consumer Care should modify TV ads comparing the company's Aleve analgesic with McNeil Consumer and Specialty Pharmaceuticals' Tylenol "to avoid conveying a 'doctor recommended message,'" the National Advertising Division of the Council of Better Business Bureaus says
Aleve “Doctor Recommended” Ad Claim Has No “Reasonable Basis” – NAD
Bayer Consumer Care should modify TV ads comparing the company's Aleve analgesic with McNeil Consumer and Specialty Pharmaceuticals' Tylenol "to avoid conveying a 'doctor recommended message,'" the National Advertising Division of the Council of Better Business Bureaus says
Aleve “Doctor Recommended” Ad Claim Has No “Reasonable Basis” – NAD
Bayer Consumer Care should modify TV ads comparing the company's Aleve analgesic with McNeil Consumer and Specialty Pharmaceuticals' Tylenol "to avoid conveying a 'doctor recommended message,'" the National Advertising Division of the Council of Better Business Bureaus says